What is the initial management for a patient presenting with Diabetic Ketoacidosis (DKA)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 1, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

SOAP Note for Diabetic Ketoacidosis (DKA)

Subjective

Chief Complaint & History of Present Illness:

  • Document duration and progression of polyuria, polydipsia, nausea, vomiting, abdominal pain, and altered mental status 1
  • Identify precipitating factors: recent infection (most common), new diabetes diagnosis, insulin omission/non-adherence, medication changes (especially SGLT2 inhibitors, corticosteroids, thiazides), myocardial infarction, stroke, pancreatitis, trauma, or alcohol abuse 1, 2
  • Obtain insulin regimen details and recent adherence patterns 1
  • Review sick-day management and recent illness 3

Past Medical History:

  • Type 1 vs Type 2 diabetes history and control 1
  • Previous DKA episodes 3
  • Cardiac or renal disease (affects fluid management) 4

Objective

Initial Vital Signs & Physical Examination:

  • Assess severity of dehydration: dry mucous membranes, poor skin turgor, hypotension, tachycardia (typical deficit: 6L or 100 ml/kg body weight) 4, 2
  • Mental status: alert (mild DKA), drowsy (moderate), stupor/coma (severe) 5
  • Respiratory pattern: Kussmaul respirations (deep, rapid breathing) 1
  • Cardiac examination: assess for signs of myocardial infarction (can precipitate and be masked by DKA) 1
  • Neurological examination: focal deficits suggesting stroke as precipitant 1
  • Signs of infection: obtain cultures from urine, blood, throat if suspected 4, 2

Initial Laboratory Evaluation (STAT):

Diagnostic Criteria for DKA:

  • Blood glucose >250 mg/dL 1, 5, 2
  • Venous pH <7.3 1, 5, 2
  • Serum bicarbonate <15 mEq/L 1, 5, 2
  • Moderate ketonuria or ketonemia (β-hydroxybutyrate preferred over nitroprusside method) 1, 5

Severity Classification:

  • Mild: pH 7.25-7.30, bicarbonate 15-18 mEq/L, alert 5
  • Moderate: pH 7.00-7.24, bicarbonate 10-15 mEq/L, drowsy 5
  • Severe: pH <7.00, bicarbonate <10 mEq/L, stupor/coma 5

Complete Metabolic Panel:

  • Calculate anion gap: [Na+] - ([Cl-] + [HCO3-]), should be >10-12 mEq/L 5, 2
  • Calculate corrected sodium: add 1.6 mEq/L for every 100 mg/dL glucose above 100 mg/dL 4, 1, 2
  • Potassium level (critical: total body depletion of 3-5 mEq/kg despite potentially normal/elevated initial levels) 4, 1, 2
  • BUN/creatinine, serum osmolality 4, 5

Additional Labs:

  • β-hydroxybutyrate (gold standard for ketone measurement, not nitroprusside-based tests) 1, 5
  • Complete blood count with differential 4, 2
  • Arterial or venous blood gas 4, 5
  • Urinalysis with urine ketones 4
  • HbA1c (distinguishes acute vs chronic poor control) 4, 5
  • Blood lactate (if lactic acidosis suspected) 5

Ancillary Studies:

  • Electrocardiogram (assess for MI, monitor for hypokalemia changes) 4, 2
  • Chest X-ray if respiratory symptoms present 4
  • Bacterial cultures if infection suspected 4, 2

Assessment

Primary Diagnosis: Diabetic Ketoacidosis - [Mild/Moderate/Severe based on pH and bicarbonate] 5

Severity Stratification:

  • pH <7.00 and bicarbonate <10 mEq/L indicates severe DKA requiring intensive monitoring 5

Precipitating Factor: [Identify specific cause: infection, insulin omission, new diagnosis, SGLT2 inhibitor use, MI, etc.] 1, 2

Differential Diagnosis to Exclude:

  • Alcoholic ketoacidosis (glucose typically <250 mg/dL or hypoglycemic) 4
  • Starvation ketosis (bicarbonate usually >18 mEq/L) 4
  • Lactic acidosis 5
  • Toxic ingestions (salicylate, methanol, ethylene glycol) 4, 5

Plan

1. Fluid Resuscitation

First Hour:

  • Administer isotonic saline (0.9% NaCl) at 15-20 mL/kg/hour (approximately 1-1.5 L in average adult) to restore circulatory volume and renal perfusion 4, 1, 2

Subsequent Fluid Management:

  • If corrected sodium is normal or elevated: use 0.45% NaCl at 4-14 mL/kg/hour 4
  • If corrected sodium is low: continue 0.9% NaCl at similar rate 4
  • Target: correct estimated 6-9L deficit within 24 hours 4, 2
  • When glucose reaches 250 mg/dL: change to 5% dextrose with 0.45-0.75% NaCl while continuing insulin to prevent hypoglycemia and allow complete ketone clearance 1, 5

Critical Monitoring:

  • Monitor for fluid overload in patients with cardiac or renal compromise 4
  • Change in serum osmolality should not exceed 3 mOsm/kg/h 4

2. Insulin Therapy

For Moderate-Severe DKA or Critically Ill/Obtunded Patients:

  • Start continuous IV regular insulin at 0.1 units/kg/hour (standard of care) 1, 2
  • No initial bolus required (per most recent guidelines) 1
  • Target glucose decline: 50-75 mg/dL per hour 1
  • If glucose does not fall by 50 mg/dL in first hour: check hydration status; if adequate, double insulin infusion rate hourly until steady decline achieved 1

For Mild-Moderate Uncomplicated DKA (Hemodynamically Stable, Alert Patients):

  • Alternative approach: subcutaneous rapid-acting insulin analogs at 0.15 units/kg every 2-3 hours combined with aggressive fluid management (equally effective, safer, more cost-effective) 1

Critical Rule:

  • Continue insulin infusion until DKA resolution (pH >7.3, bicarbonate ≥18 mEq/L, anion gap ≤12 mEq/L) regardless of glucose levels 1
  • Target glucose 150-200 mg/dL during treatment by adding dextrose, NOT by stopping insulin 1

3. Potassium Management

CRITICAL ALGORITHM:

If K+ <3.3 mEq/L:

  • HOLD insulin therapy 1
  • Aggressively replace potassium first until ≥3.3 mEq/L to prevent fatal cardiac arrhythmias 1

If K+ 3.3-5.5 mEq/L:

  • Add 20-30 mEq/L potassium to each liter of IV fluid (use 2/3 KCl and 1/3 KPO4) once adequate urine output confirmed 4, 1, 2

If K+ >5.5 mEq/L:

  • Withhold potassium initially but monitor closely every 2-4 hours, as levels will drop rapidly with insulin therapy 1

Target: maintain serum K+ between 4-5 mEq/L throughout treatment 1

4. Bicarbonate Therapy

The American Diabetes Association recommends AGAINST bicarbonate use for pH >6.9-7.0 1

  • No benefit in resolution time or outcomes 1
  • May worsen ketosis, cause hypokalemia, and increase cerebral edema risk 1
  • Consider only if pH <6.9 1

5. Monitoring Protocol

Every 2-4 Hours:

  • Serum electrolytes, glucose, BUN, creatinine, osmolality, venous pH 1, 5
  • β-hydroxybutyrate (preferred over urine ketones) 1, 5
  • Potassium levels (critical to prevent hypokalemia) 1

Avoid Pitfall:

  • Do NOT use nitroprusside-based ketone tests for monitoring; they only measure acetoacetate/acetone, not β-hydroxybutyrate, and can falsely suggest worsening during treatment 1, 5

6. Resolution Criteria

DKA is resolved when ALL of the following are met:

  • Glucose <200 mg/dL 1, 5
  • Serum bicarbonate ≥18 mEq/L 1, 5
  • Venous pH >7.3 1, 5
  • Anion gap ≤12 mEq/L 1, 5

7. Transition to Subcutaneous Insulin

CRITICAL TIMING:

  • Administer basal insulin (glargine or detemir) 2-4 hours BEFORE stopping IV insulin infusion to prevent recurrence of ketoacidosis and rebound hyperglycemia 1
  • Once patient can eat, start multiple-dose schedule with combination of rapid-acting and long-acting insulin 1

Common Pitfall to Avoid:

  • Stopping IV insulin when glucose normalizes causes recurrent ketoacidosis, as ketone clearance takes longer than glucose normalization 1

8. Treatment of Precipitating Cause

Concurrent Management:

  • Administer appropriate antibiotics if infection identified 4, 2
  • Treat myocardial infarction, stroke, or other precipitants 1
  • Discontinue SGLT2 inhibitors immediately and do not restart until 3-4 days after metabolic stability achieved 1

9. Cerebral Edema Prevention

High-Risk Scenario (especially children/adolescents):

  • Monitor closely for altered mental status, headache, neurological deterioration 1
  • Avoid overly rapid correction of osmolality 4, 1

10. Discharge Planning

Before Discharge:

  • Identify outpatient diabetes care providers 1
  • Educate on glucose monitoring, insulin administration, sick-day management 1, 3
  • Ensure appropriate insulin regimen prescribed with attention to medication access/affordability 1
  • Teach recognition and prevention of DKA recurrence 1, 3
  • Schedule follow-up appointment 1

References

Guideline

Assessment and Management of Diabetic Ketoacidosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Diabetic Ketoacidosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Management of Diabetic Ketoacidosis in Adults: A Narrative Review.

Saudi journal of medicine & medical sciences, 2020

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnostic Criteria and Management of Diabetic Ketoacidosis (DKA)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.